US Tariff Move on Patented Drugs Leaves India Largely Unaffected: Generics Keep ‘Pharmacy of the World’ Strong
India’s pharmaceutical sector appears relatively shielded from the latest tariff action announced by the Donald Trump, thanks to its stronghold in low-cost generic medicines. A recent analysis...















